Palo Alto Investors’s Aldeyra Therapeutics ALDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$864K	Hold	225,465	–	–	0.18%	38
2025 Q1	$1.3M	Hold	225,465	–	–	0.25%	32
2024 Q4	$1.13M	Hold	225,465	–	–	0.17%	35
2024 Q3	$1.22M	Hold	225,465	–	–	0.16%	36
2024 Q2	$746K	Hold	225,465	–	–	0.09%	36
2024 Q1	$737K	Hold	225,465	–	–	0.08%	36
2023 Q4	$791K	Buy	225,465 +64,665	+40%	+$227K	0.07%	33
2023 Q3	$1.07M	Hold	160,800	–	–	0.1%	26
2023 Q2	$1.35M	Hold	160,800	–	–	0.11%	27
2023 Q1	$1.6M	Hold	160,800	–	–	0.13%	25
2022 Q4	$1.12M	Hold	160,800	–	–	0.1%	25
2022 Q3	$859K	Hold	160,800	–	–	0.07%	28
2022 Q2	$642K	Hold	160,800	–	–	0.06%	29
2022 Q1	$715K	Hold	160,800	–	–	0.06%	31
2021 Q4	$643K	Hold	160,800	–	–	0.04%	34
2021 Q3	$1.41M	Hold	160,800	–	–	0.09%	33
2021 Q2	$1.82M	Hold	160,800	–	–	0.1%	34
2021 Q1	$1.91M	Hold	160,800	–	–	0.11%	34
2020 Q4	$1.1M	Buy	160,800 +42,800	+36%	+$294K	0.06%	34
2020 Q3	$874K	Buy	118,000 +44,500	+61%	+$330K	0.05%	37
2020 Q2	$306K	Hold	73,500	–	–	0.02%	38
2020 Q1	$182K	Hold	73,500	–	–	0.02%	36
2019 Q4	$427K	Hold	73,500	–	–	0.02%	31
2019 Q3	$387K	Hold	73,500	–	–	0.03%	32
2019 Q2	$441K	Buy	+73,500	New	+$441K	0.02%	34